Skip to main content
Clinical Trials/JPRN-UMIN000006387
JPRN-UMIN000006387
Not yet recruiting
Phase 2

Clinical study on the intravesical instillation of heparin, lidocain and bicarbonate for the patients with interstitial cystitis - Heparin, lidocain and bicarbonate for interstitial cystitis

niversity of Tokushima0 sites30 target enrollmentOctober 31, 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Tokushima
Enrollment
30
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 31, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Tokushima

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with cystitis other than interstitial cystitis or patients with bladder neoplasms

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Clinacal study on the intravesical instillation of dimethylsulfoxide (DMSO) for the patients with interstitial cystitisInterstitial cystitis
JPRN-UMIN000003172Deparment of Urology, Medical Science, University of Fukui30
Active, not recruiting
Not Applicable
Pilot Study of the Intravesical Administration of EOquin Immediately Following Transurethral Resection in Patients with Superficial Bladder Cancer. - Not applicableBladder Cancer Stage 1 without Cancer in SituPatients will have transitional-cell carcinoma of the bladder, clinical TNM stage Ta or T1 and histologic grade G1 or G2 before transurethral resection.MedDRA version: 9Level: PTClassification code 10005009
EUCTR2006-002372-18-NLSpectrum Pharmaceuticals, Inc.20
Recruiting
Not Applicable
Prospective study of the efficacy of intravesical chemotherapy with THP against subsequent bladder cancer after nephrouretectomy (NUx) for upper urinary tract carcinoma (UUTC).rothelial carcinoma of upper urinary tract
JPRN-UMIN000005767Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science.100
Recruiting
Phase 3
Assessment of the therapeutic effect of intravesical Gemcitabine in patients with bladder cancer.
IRCT20200402046915N1Shahid Beheshti University of Medical Sciences110
Active, not recruiting
Not Applicable
ot availableTreatment of urinary tract infectionMedDRA version: 14.1Level: PTClassification code 10046571Term: Urinary tract infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: HLTClassification code 10046577Term: Urinary tract infectionsSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2011-004594-82-BGSchur Pharmazeutika GmbH & Co. KG